52 In the WHI trial, there was a 26% increase in invasive breast cancer risk in the CEE/MPA group compared to the placebo group, which did not reach statistical significance (HR=1.26; 95% CI, 1.00-1.59).
← all excerpts
Efficacy and safety of estrogen therapy for prevention of osteoporosis in postmenopausal women.
1
—
—